Literature DB >> 23871893

Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1.

Matthew W Parker1, Andrew D Linkugel, Craig W Vander Kooi.   

Abstract

Neuropilins (Nrp) are type I transmembrane proteins that function as receptors for vascular endothelial growth factor (VEGF) and class III Semaphorin (Sema3) ligand families. Sema3s function as potent endogenous angiogenesis inhibitors but require proteolytically processing by furin to compete with VEGF for Nrp binding. This processing liberates a C-terminal arginine (CR) that is necessary for binding to the b1 domain of Nrp, a common feature shared by Nrp ligands. The CR is necessary but not sufficient for potent Nrp inhibition, and the role of upstream residues is unknown. We demonstrate that the second-to-last residue (C-1), immediately upstream of the CR, plays a significant role in controlling competitive ligand binding by orienting the C-terminus for productive Nrp binding. With the use of a peptide library derived from Sema3F, C-1 residues that preferentially adopt an extended bound-like conformation, including proline and β-branched amino acids, were found to produce the most avid competitors. Consistent with this, analysis of the binding thermodynamics revealed that more favorable entropy is responsible for the observed binding enhancement of C-1 proline. We further tested the effect of the C-1 residue on Sema3F processing by furin and found an inverse relationship between processing and inhibitory potency. Analysis of all Sema3 family members reveals two non-equivalent furin processing sites differentiated by the presence of either a C-1 proline or a C-1 arginine and resulting in up to a 40-fold difference in potency. These data reveal a novel regulatory mechanism of Sema3 activity and define a fundamental mechanism for preferential Nrp binding.
© 2013.

Entities:  

Keywords:  AP; CHO; Chinese hamster ovary; ITC; Sema3; VEGF; alkaline phosphatase; angiogenesis; class III Semaphorin; furin; isothermal titration calorimetry; peptide library; proteolysis; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 23871893      PMCID: PMC4038064          DOI: 10.1016/j.jmb.2013.07.017

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  50 in total

1.  Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.

Authors:  M L Gagnon; D R Bielenberg; Z Gechtman; H Q Miao; S Takashima; S Soker; M Klagsbrun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  A mammalian expression vector for expression and purification of secreted proteins for structural studies.

Authors:  D J Leahy; C E Dann; P Longo; B Perman; K X Ramyar
Journal:  Protein Expr Purif       Date:  2000-12       Impact factor: 1.650

3.  Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach.

Authors:  Nurit Haspel; David Zanuy; Ruth Nussinov; Tambet Teesalu; Erkki Ruoslahti; Carlos Aleman
Journal:  Biochemistry       Date:  2011-02-14       Impact factor: 3.162

4.  VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation.

Authors:  Birger Herzog; Caroline Pellet-Many; Gary Britton; Basil Hartzoulakis; Ian C Zachary
Journal:  Mol Biol Cell       Date:  2011-06-08       Impact factor: 4.138

5.  Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system.

Authors:  B A Jardin; Y Zhao; M Selvaraj; J Montes; R Tran; S Prakash; C B Elias
Journal:  J Biotechnol       Date:  2008-05-21       Impact factor: 3.307

Review 6.  Function of members of the neuropilin family as essential pleiotropic cell surface receptors.

Authors:  Matthew W Parker; Hou-Fu Guo; Xiaobo Li; Andrew D Linkugel; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

7.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.

Authors:  Tambet Teesalu; Kazuki N Sugahara; Venkata Ramana Kotamraju; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-02       Impact factor: 11.205

8.  Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.

Authors:  Matthew W Parker; Ping Xu; Hou-Fu Guo; Craig W Vander Kooi
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

9.  GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation.

Authors:  Hira Lal Goel; Bryan Pursell; Cheng Chang; Leslie M Shaw; Junhao Mao; Karl Simin; Prashant Kumar; Craig W Vander Kooi; Leonard D Shultz; Dale L Greiner; Jens Henrik Norum; Rune Toftgard; Charlotte Kuperwasser; Arthur M Mercurio
Journal:  EMBO Mol Med       Date:  2013-02-21       Impact factor: 12.137

Review 10.  VEGF-A splicing: the key to anti-angiogenic therapeutics?

Authors:  Steven J Harper; David O Bates
Journal:  Nat Rev Cancer       Date:  2008-10-16       Impact factor: 60.716

View more
  17 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

2.  Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.

Authors:  Matthew W Parker; Andrew D Linkugel; Hira Lal Goel; Tingting Wu; Arthur M Mercurio; Craig W Vander Kooi
Journal:  Structure       Date:  2015-03-05       Impact factor: 5.006

3.  Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F.

Authors:  Hou-Fu Guo; Xiaobo Li; Matthew W Parker; Johannes Waltenberger; Patrice M Becker; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2013-10-18       Impact factor: 3.162

4.  Isolation of Primary Hepatocytes for Testing Tumor Penetrating Peptides.

Authors:  Eric Savier; Pierre Tuffery; Heriberto Bruzzoni-Giovanelli; Angelita Rebollo
Journal:  Methods Mol Biol       Date:  2022

5.  Microplate-based screening for small molecule inhibitors of neuropilin-2/vascular endothelial growth factor-C interactions.

Authors:  Matthew W Parker; Craig W Vander Kooi
Journal:  Anal Biochem       Date:  2014-02-26       Impact factor: 3.365

Review 6.  Control of cellular motility by neuropilin-mediated physical interactions.

Authors:  Xiaobo Li; Matthew W Parker; Craig W Vander Kooi
Journal:  Biomol Concepts       Date:  2014-05

7.  Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.

Authors:  Haig Aghajanian; Connie Choi; Vivienne C Ho; Mudit Gupta; Manvendra K Singh; Jonathan A Epstein
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

Review 8.  Neuropilin 1 Regulation of Vascular Permeability Signaling.

Authors:  Alison Domingues; Alessandro Fantin
Journal:  Biomolecules       Date:  2021-04-29

9.  Design, synthesis, and evaluation of a novel benzamidine-based inhibitor of VEGF-C binding to Neuropilin-2.

Authors:  Ahmed M Said; Matthew W Parker; Craig W Vander Kooi
Journal:  Bioorg Chem       Date:  2020-04-16       Impact factor: 5.307

10.  Tumor-penetrating iRGD peptide inhibits metastasis.

Authors:  Kazuki N Sugahara; Gary B Braun; Tatiana Hurtado de Mendoza; Venkata Ramana Kotamraju; Randall P French; Andrew M Lowy; Tambet Teesalu; Erkki Ruoslahti
Journal:  Mol Cancer Ther       Date:  2014-11-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.